{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:05:19Z","timestamp":1774127119684,"version":"3.50.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2015-68346-P"],"award-info":[{"award-number":["SAF2015-68346-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF 2015-68346-P"],"award-info":[{"award-number":["SAF 2015-68346-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PI16\/00287"],"award-info":[{"award-number":["PI16\/00287"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2015-68346-P"],"award-info":[{"award-number":["SAF2015-68346-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014-SGR798"],"award-info":[{"award-number":["2014-SGR798"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2016FI-B00285"],"award-info":[{"award-number":["2016FI-B00285"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017-SGR717"],"award-info":[{"award-number":["2017-SGR717"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017-SGR717"],"award-info":[{"award-number":["2017-SGR717"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014-SGR798"],"award-info":[{"award-number":["2014-SGR798"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017-SGR717"],"award-info":[{"award-number":["2017-SGR717"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014-SGR798"],"award-info":[{"award-number":["2014-SGR798"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017-SGR717"],"award-info":[{"award-number":["2017-SGR717"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBERSAM"],"award-info":[{"award-number":["CIBERSAM"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CERCA Programme"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute ketamine administration evokes rapid and sustained antidepressant effects in treatment-resistant patients. However, ketamine also produces transient perceptual disturbances similarly to those evoked by other non-competitive NMDA-R antagonists like phencyclidine (PCP). Although the brain networks involved in both ketamine actions are not fully understood, PCP and ketamine activate thalamo-cortical networks after NMDA-R blockade in GABAergic neurons of the reticular thalamic nucleus (RtN). Given the involvement of thalamo-cortical networks in processing sensory information, these networks may underlie psychotomimetic action. Since the GluN2C subunit is densely expressed in the thalamus, including the RtN, we examined the dependence of psychotomimetic and antidepressant-like actions of ketamine on the presence of GluN2C subunits, using wild-type and GluN2C knockout (GluN2CKO) mice. Likewise, since few studies have investigated ketamine\u2019s effects in females, we used mice of both sexes. GluN2C deletion dramatically reduced stereotyped (circling) behavior induced by ketamine in male and female mice, while the antidepressant-like effect was fully preserved in both genotypes and sexes. Despite ketamine appeared to induce similar effects in both sexes, some neurobiological differences were observed between male and female mice regarding <jats:italic>c-fos<\/jats:italic> expression in thalamic nuclei and cerebellum, and glutamate surge in prefrontal cortex. In conclusion, the GluN2C subunit may discriminate between antidepressant-like and psychotomimetic actions of ketamine. Further, the abundant presence of GluN2C subunits in the cerebellum and the improved motor coordination of GluN2CKO mice after ketamine treatment suggest the involvement of cerebellar NMDA-Rs in some behavioral actions of ketamine.<\/jats:p>","DOI":"10.1038\/s41398-020-01110-y","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T12:03:03Z","timestamp":1607601783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine"],"prefix":"10.1038","volume":"10","author":[{"given":"Mireia","family":"Tarr\u00e9s-Gatius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Miquel-Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Campa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-445X","authenticated-orcid":false,"given":"Anna","family":"Casta\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"1110_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers, C. D. & Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442 (2006).","journal-title":"PLoS Med."},{"key":"1110_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2011.11.005","volume":"35","author":"RC Kessler","year":"2012","unstructured":"Kessler, R. C. The costs of depression. Psychiatr. Clin. North Am. 35, 1\u201314 (2012).","journal-title":"Psychiatr. Clin. North Am."},{"key":"1110_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.15252\/embr.201642951","volume":"17","author":"S Trautmann","year":"2016","unstructured":"Trautmann, S., Rehm, J. & Wittchen, H. The economic costs of mental disorders: do our societies react appropriately to the burden of mental disorders? EMBO Rep. 17, 1245\u20131249 (2016).","journal-title":"EMBO Rep."},{"key":"1110_CR4","unstructured":"WHO. Depression and other common mental disorders: global health estimates. World Health Organ. WHO\/MSD\/MER\/2017.2, 1\u201324 (2017)."},{"key":"1110_CR5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1176\/ps.2009.60.11.1466","volume":"60","author":"T Insel","year":"2009","unstructured":"Insel, T. & Wang, P. S. The STAR*D trial: revealing the need for better treatments. Psychiatr. Serv. 60, 1466\u20131467 (2009).","journal-title":"Psychiatr. Serv."},{"key":"1110_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman, R. M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351\u2013354 (2000).","journal-title":"Biol. Psychiatry"},{"key":"1110_CR7","first-page":"1","volume":"19","author":"Y Xu","year":"2006","unstructured":"Xu, Y. et al. Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 19, 1\u201315 (2006).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate, C. A. et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63, 856\u2013864 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1110_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","volume":"75","author":"EJ Daly","year":"2018","unstructured":"Daly, E. J. et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry 75, 139\u2013148 (2018).","journal-title":"JAMA Psychiatry"},{"key":"1110_CR10","unstructured":"FDA News Release on March 5, 2019. FDA Approves New Nasal Spray Medication for Treatment-resistant Depression. Available Only at a Certified Doctor\u2019s Office or Clinic. https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm632761.html (2019)."},{"key":"1110_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/acps.12572","volume":"134","author":"CK Loo","year":"2016","unstructured":"Loo, C. K. et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr. Scand. 134, 48\u201356 (2016).","journal-title":"Acta Psychiatr. Scand."},{"key":"1110_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","volume":"230","author":"B Romeo","year":"2015","unstructured":"Romeo, B., Choucha, W., Fossati, P. & Rotge, J. Y. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Psychiatry Res. 230, 682\u2013688 (2015).","journal-title":"Psychiatry Res."},{"key":"1110_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2019.00616","volume":"13","author":"B Derntl","year":"2019","unstructured":"Derntl, B. et al. Interaction of sex and age on the dissociative effects of ketamine action in young healthy participants. Front. Neurosci. 13, 1\u20138 (2019).","journal-title":"Front. Neurosci."},{"key":"1110_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neubiorev.2017.03.010","volume":"77","author":"F Bartoli","year":"2017","unstructured":"Bartoli, F. et al. Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis. Neurosci. Biobehav. Rev. 77, 232\u2013236 (2017).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1110_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","volume":"175","author":"ST Wilkinson","year":"2018","unstructured":"Wilkinson, S. T. et al. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am. J. Psychiatry 175, 150\u2013158 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"1110_CR16","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.4088\/JCP.13m08698","volume":"75","author":"MJ Niciu","year":"2014","unstructured":"Niciu, M. J. et al. Clinical predictors of ketamine response in treatment-resistant major depression. J. Clin. Psychiatry 75, e417\u2013e423 (2014).","journal-title":"J. Clin. Psychiatry"},{"key":"1110_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","volume":"74","author":"G Sanacora","year":"2017","unstructured":"Sanacora, G. et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 74, 399\u2013405 (2017).","journal-title":"JAMA Psychiatry"},{"key":"1110_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos, P. & Gould, T. D. Mechanisms of ketamine action as an antidepressant. Mol. Psychiatry 23, 801\u2013811 (2018).","journal-title":"Mol. Psychiatry"},{"key":"1110_CR19","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","volume":"27","author":"H Homayoun","year":"2007","unstructured":"Homayoun, H. & Moghaddam, B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 27, 11496\u201311500 (2007).","journal-title":"J. Neurosci."},{"key":"1110_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","volume":"42","author":"G Tsai","year":"2002","unstructured":"Tsai, G. & Coyle, J. T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 42, 165\u2013179 (2002).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1110_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuropharm.2018.04.022","volume":"137","author":"M Amat-Foraster","year":"2018","unstructured":"Amat-Foraster, M. et al. Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks. Neuropharmacology 137, 13\u201323 (2018).","journal-title":"Neuropharmacology"},{"key":"1110_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.biopsych.2014.05.019","volume":"76","author":"E Troyano-Rodriguez","year":"2014","unstructured":"Troyano-Rodriguez, E. et al. Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Biol. Psychiatry 76, 937\u2013945 (2014).","journal-title":"Biol. Psychiatry"},{"key":"1110_CR23","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1017\/S1461145713000643","volume":"16","author":"P Celada","year":"2013","unstructured":"Celada, P. et al. Disruption of thalamocortical activity in schizophrenia models: Relevance to antipsychotic drug action. Int. J. Neuropsychopharmacol. 16, 2145\u20132163 (2013).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR24","doi-asserted-by":"publisher","first-page":"14843","DOI":"10.1073\/pnas.0704848104","volume":"104","author":"L Kargieman","year":"2007","unstructured":"Kargieman, L., Santana, N., Mengod, G., Celada, P. & Artigas, F. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. Proc. Natl Acad. Sci. USA 104, 14843\u201314848 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1110_CR25","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.biopsych.2010.10.030","volume":"69","author":"N Santana","year":"2011","unstructured":"Santana, N., Troyano-Rodriguez, E., Mengod, G., Celada, P. & Artigas, F. Activation of thalamocortical networks by the N-methyl-d-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biol. Psychiatry 69, 918\u2013927 (2011).","journal-title":"Biol. Psychiatry"},{"key":"1110_CR26","doi-asserted-by":"publisher","first-page":"107745","DOI":"10.1016\/j.neuropharm.2019.107745","volume":"158","author":"M Amat-Foraster","year":"2019","unstructured":"Amat-Foraster, M. et al. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat. Neuropharmacology 158, 107745 (2019).","journal-title":"Neuropharmacology"},{"key":"1110_CR27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.euroneuro.2015.11.015","volume":"26","author":"L Llad\u00f3-Pelfort","year":"2016","unstructured":"Llad\u00f3-Pelfort, L. et al. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: effects of antipsychotic drugs and receptor ligands. Eur. Neuropshychopharmacol. 26, 614\u2013625 (2016).","journal-title":"Eur. Neuropshychopharmacol."},{"key":"1110_CR28","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.euroneuro.2017.10.034","volume":"27","author":"HE van den Munkhof","year":"2017","unstructured":"van den Munkhof, H. E., Arnt, J., Celada, P. & Artigas, F. The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks. Eur. Neuropsychopharmacol. 27, 1248\u20131257 (2017).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1110_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos, P. et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533, 481\u2013486 (2016).","journal-title":"Nature"},{"key":"1110_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li, N. et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959\u2013964 (2010).","journal-title":"Science"},{"key":"1110_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","volume":"29","author":"W Zhou","year":"2014","unstructured":"Zhou, W. et al. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur. Psychiatry 29, 419\u2013423 (2014).","journal-title":"Eur. Psychiatry"},{"key":"1110_CR32","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41386-020-0668-1","volume":"45","author":"CG Abdallah","year":"2020","unstructured":"Abdallah, C. G. (2R,6R)-Hydroxynorketamine (HNK) plasma level predicts poor antidepressant response: is this the end of the HNK pipeline? Neuropsychopharmacology 45, 1245\u20131246 (2020).","journal-title":"Neuropsychopharmacology"},{"key":"1110_CR33","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1523\/JNEUROSCI.3703-08.2009","volume":"29","author":"SE Kotermanski","year":"2009","unstructured":"Kotermanski, S. E. & Johnson, J. W. Mg2+imparts NMDA receptor subtype selectivity to the Alzheimer\u2019s drug memantine. J. Neurosci. 29, 2774\u20132779 (2009).","journal-title":"J. Neurosci."},{"key":"1110_CR34","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.1523\/JNEUROSCI.1203-16.2016","volume":"36","author":"E Khlestova","year":"2016","unstructured":"Khlestova, E., Johnson, J. W., Krystal, J. H. & Lisman, J. The role of GluN2C-containing NMDA receptors in ketamine\u2019s psychotogenic action and in schizophrenia models. J. Neurosci. 36, 11151\u201311157 (2016).","journal-title":"J. Neurosci."},{"key":"1110_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/368335a0","volume":"368","author":"M Farrant","year":"1994","unstructured":"Farrant, M., Feldmeyer, D., Takahashi, T. & Cull-Candy, S. G. NMDA-receptor channel diversity in the developing cerebellum. Nature 368, 335\u2013339 (1994).","journal-title":"Nature"},{"key":"1110_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.mcn.2006.12.001","volume":"34","author":"I Karavanova","year":"2007","unstructured":"Karavanova, I., Vasudevan, K., Cheng, J. & Buonanno, A. Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-\u03b2-galactosidase knock-in mice. Mol. Cell. Neurosci. 34, 468\u2013480 (2007).","journal-title":"Mol. Cell. Neurosci."},{"key":"1110_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","volume":"12","author":"H Monyer","year":"1994","unstructured":"Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B. & Seeburg, P. H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529\u2013540 (1994).","journal-title":"Neuron"},{"key":"1110_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1471-4159.1997.68020469.x","volume":"68","author":"A Wenzel","year":"1997","unstructured":"Wenzel, A., Fritschy, J. M., Mohler, H. & Benke, D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68, 469\u2013478 (1997).","journal-title":"J. Neurochem."},{"key":"1110_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuroscience.2018.03.011","volume":"380","author":"A Ravikrishnan","year":"2018","unstructured":"Ravikrishnan, A. et al. Region-specific expression of NMDA receptor GluN2C subunit in parvalbumin-positive neurons and astrocytes: analysis of GluN2C expression using a novel reporter model. Neuroscience 380, 49\u201362 (2018).","journal-title":"Neuroscience"},{"key":"1110_CR40","first-page":"1","volume":"3","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y., Llinas, R. R. & Lisman, J. E. Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting. Front. Neural Circuits 3, 1\u20139 (2009).","journal-title":"Front. Neural Circuits"},{"key":"1110_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041908","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y., Buonanno, A., Vertes, R. P., Hoover, W. B. & Lisman, J. E. NR2C in the thalamic reticular nucleus; effects of the NR2C knockout. PLoS ONE 7, e41908 (2012).","journal-title":"PLoS ONE"},{"key":"1110_CR42","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1523\/JNEUROSCI.16-16-05014.1996","volume":"16","author":"AK Ebralidze","year":"1996","unstructured":"Ebralidze, A. K., Rossi, D. J., Tonegawa, S. & Slater, T. Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene. J. Neurosci. 16, 5014\u20135025 (1996).","journal-title":"J. Neurosci."},{"key":"1110_CR43","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1523\/JNEUROSCI.20-16-05899.2000","volume":"20","author":"L Cathala","year":"2000","unstructured":"Cathala, L., Misra, C. & Cull-Candy, S. Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses. J. Neurosci. 20, 5899\u20135905 (2000).","journal-title":"J. Neurosci."},{"key":"1110_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1503\/jpn.150205","volume":"40","author":"PR Albert","year":"2015","unstructured":"Albert, P. R. Why is depression more prevalent in women? J. Psychiatry Neurosci. 40, 219\u2013221 (2015).","journal-title":"J. Psychiatry Neurosci."},{"key":"1110_CR45","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/npp.2015.233","volume":"41","author":"K Fukumoto","year":"2016","unstructured":"Fukumoto, K., Iijima, M. & Chaki, S. The antidepressant effects of an mGlu2\/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN. Neuropsychopharmacology 41, 1046\u20131056 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"1110_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuropharm.2010.04.012","volume":"59","author":"MC Scorza","year":"2010","unstructured":"Scorza, M. C., Casta\u00f1\u00e9, A., Bortolozzi, A. & Artigas, F. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801. Clz and MK-801 in KO1A mice. Neuropharmacology 59, 112\u2013120 (2010).","journal-title":"Neuropharmacology"},{"key":"1110_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0091-3057(89)90044-0","volume":"32","author":"LJ Spanos","year":"1989","unstructured":"Spanos, L. J. & Yamamoto, B. K. Acute and subchronic effects of methylenedioxymethamphetamine [(+\/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol. Biochem. Behav. 32, 835\u2013840 (1989).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"1110_CR48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00213-008-1205-9","volume":"200","author":"A Casta\u00f1\u00e9","year":"2008","unstructured":"Casta\u00f1\u00e9, A., Artigas, F. & Bortolozzi, A. The absence of 5-HT1A receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex. Psychopharmacology 200, 281\u2013290 (2008).","journal-title":"Psychopharmacology"},{"key":"1110_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1017\/S1461145708009267","volume":"12","author":"X L\u00f3pez-Gil","year":"2009","unstructured":"L\u00f3pez-Gil, X., Artigas, F. & Adell, A. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action. Int. J. Neuropsychopharmacol. 12, 487\u2013499 (2009).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR50","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","volume":"14","author":"N Santana","year":"2004","unstructured":"Santana, N., Bortolozzi, A., Serrats, J., Mengod, G. & Artigas, F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb. Cortex 14, 1100\u20131109 (2004).","journal-title":"Cereb. Cortex"},{"key":"1110_CR51","unstructured":"Franklin K. B. J. & Paxinos G. The Mouse Brain in Stereotaxi Coordinates, 3rd edn. (Elsevier Academic Press, London, 2007)."},{"key":"1110_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"9","author":"N Otsu","year":"1979","unstructured":"Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cybern. 9, 62\u201366 (1979).","journal-title":"IEEE Trans. Syst. Man Cybern."},{"key":"1110_CR53","doi-asserted-by":"crossref","unstructured":"Tarr\u00e9s-Gatius, M. et al. Involvement of the GluN2C subunit in the behavioural syndrome induced by non-competitive NMDA antagonists. Eur. Neuropsychopharmacol. 28, abstr. S37 (2018).","DOI":"10.1016\/j.euroneuro.2017.12.063"},{"key":"1110_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpsychires.2018.02.006","volume":"100","author":"DB Fraga","year":"2018","unstructured":"Fraga, D. B. et al. Anxiolytic effects of ascorbic acid and ketamine in mice. J. Psychiatr. Res. 100, 16\u201323 (2018).","journal-title":"J. Psychiatr. Res."},{"key":"1110_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12311-011-0331-9","volume":"11","author":"M Manto","year":"2012","unstructured":"Manto, M. et al. Consensus paper: roles of the cerebellum in motor control\u2014the diversity of ideas on cerebellar involvement in movement. Cerebellum 11, 457\u2013487 (2012).","journal-title":"Cerebellum"},{"key":"1110_CR56","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nlm.2011.01.008","volume":"95","author":"BG Hillman","year":"2011","unstructured":"Hillman, B. G., Gupta, S. C., Stairs, D. J., Buonanno, A. & Dravid, S. M. Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory. Neurobiol. Learn. Mem. 95, 404\u2013414 (2011).","journal-title":"Neurobiol. Learn. Mem."},{"key":"1110_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43957-2","volume":"9","author":"GP Shelkar","year":"2019","unstructured":"Shelkar, G. P. et al. Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes. Sci. Rep. 9, 7572 (2019).","journal-title":"Sci. Rep."},{"key":"1110_CR58","first-page":"1","volume":"4","author":"N Matsuo","year":"2010","unstructured":"Matsuo, N. et al. Behavioral profiles of three C57BL\/6 substrains. Front. Behav. Neurosci. 4, 1\u201312 (2010).","journal-title":"Front. Behav. Neurosci."},{"key":"1110_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-7-r82","volume":"14","author":"MM Simon","year":"2013","unstructured":"Simon, M. M. et al. A comparative phenotypic and genomic analysis of C57BL\/6J and C57BL\/6N mouse strains. Genome Biol. 14, R82 (2013).","journal-title":"Genome Biol."},{"key":"1110_CR60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1382-6689(99)00003-4","volume":"7","author":"GH Hur","year":"1999","unstructured":"Hur, G. H., Son, W. C., Shin, S., Kang, J. K. & Kim, Y. B. Sex differences in dizocilpine (MK-801) neurotoxicity in rats. Environ. Toxicol. Pharmacol. 7, 143\u2013146 (1999).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"1110_CR61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0006-8993(93)90287-W","volume":"620","author":"D H\u00f6nack","year":"1993","unstructured":"H\u00f6nack, D. & L\u00f6scher, W. Sex differences in NMDA receptor mediated responses in rats. Brain Res. 620, 167\u2013170 (1993).","journal-title":"Brain Res."},{"key":"1110_CR62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","volume":"70","author":"N Carrier","year":"2013","unstructured":"Carrier, N. & Kabbaj, M. Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70, 27\u201334 (2013).","journal-title":"Neuropharmacology"},{"key":"1110_CR63","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.biopsych.2015.12.025","volume":"80","author":"A Sarkar","year":"2016","unstructured":"Sarkar, A. & Kabbaj, M. Sex differences in effects of ketamine on behavior, spine density, and synaptic proteins in socially isolated rats. Biol. Psychiatry 80, 448\u2013456 (2016).","journal-title":"Biol. Psychiatry"},{"key":"1110_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuroscience.2015.01.008","volume":"290","author":"A Franceschelli","year":"2015","unstructured":"Franceschelli, A., Sens, J., Herchick, S., Thelen, C. & Pitychoutis, P. M. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-na\u00efve and \u2018depressed\u2019 mice exposed to chronic mild stress. Neuroscience 290, 49\u201360 (2015).","journal-title":"Neuroscience"},{"key":"1110_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuropharm.2017.11.022","volume":"130","author":"AM Dossat","year":"2018","unstructured":"Dossat, A. M., Wright, K. N., Strong, C. E. & Kabbaj, M. Behavioral and biochemical sensitivity to low doses of ketamine: influence of estrous cycle in C57BL\/6 mice. Neuropharmacology 130, 30\u201341 (2018).","journal-title":"Neuropharmacology"},{"key":"1110_CR66","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1176\/appi.ajp.2017.16080883","volume":"174","author":"CG Davey","year":"2017","unstructured":"Davey, C. G., Breakspear, M., Pujol, J. & Harrison, B. J. A brain model of disturbed self-appraisal in depression. Am. J. Psychiatry 174, 895\u2013903 (2017).","journal-title":"Am. J. Psychiatry"},{"key":"1110_CR67","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/mp.2009.146","volume":"15","author":"E Pomarol-Clotet","year":"2010","unstructured":"Pomarol-Clotet, E. et al. Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging. Mol. Psychiatry 15, 823\u2013830 (2010).","journal-title":"Mol. Psychiatry"},{"key":"1110_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.7","volume":"7","author":"J Gasull-Cam\u00f3s","year":"2017","unstructured":"Gasull-Cam\u00f3s, J., Tarr\u00e9s-Gatius, M., Artigas, F. & Casta\u00f1\u00e9, A. Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats. Transl. Psychiatry 7, e1038 (2017).","journal-title":"Transl. Psychiatry"},{"key":"1110_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuropharm.2018.06.029","volume":"139","author":"J Gasull-Cam\u00f3s","year":"2018","unstructured":"Gasull-Cam\u00f3s, J. et al. Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex. Neuropharmacology 139, 41\u201351 (2018).","journal-title":"Neuropharmacology"},{"key":"1110_CR70","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","volume":"228","author":"V Gigliucci","year":"2013","unstructured":"Gigliucci, V. et al. Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology 228, 157\u2013166 (2013).","journal-title":"Psychopharmacology"},{"key":"1110_CR71","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuropharm.2016.05.010","volume":"112","author":"TH Pham","year":"2017","unstructured":"Pham, T. H. et al. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB\/cJ mice. Neuropharmacology 112, 198\u2013209 (2017).","journal-title":"Neuropharmacology"},{"key":"1110_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/jpet.105.091199","volume":"316","author":"CR Maxwell","year":"2006","unstructured":"Maxwell, C. R. et al. Ketamine produces lasting disruptions in encoding of sensory stimuli. J. Pharmacol. Exp. Ther. 316, 315\u2013324 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1110_CR73","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/bja\/aeh144","volume":"92","author":"Y Sato","year":"2004","unstructured":"Sato, Y. et al. Chronopharmacological studies of ketamine in normal and NMDA E1 receptor knockout mice. Br. J. Anaesth. 92, 859\u2013864 (2004).","journal-title":"Br. J. Anaesth."},{"key":"1110_CR74","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1017\/S1461145705005900","volume":"9","author":"M Amarg\u00f3s-Bosch","year":"2006","unstructured":"Amarg\u00f3s-Bosch, M., L\u00f3pez-Gil, X., Artigas, F. & Adell, A. Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine. Int. J. Neuropsychopharmacol. 9, 565\u2013573 (2006).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR75","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/ijnp\/pyy007","volume":"21","author":"H Kinoshita","year":"2018","unstructured":"Kinoshita, H. et al. Ketamine-induced prefrontal serotonin release is mediated by cholinergic neurons in the pedunculopontine tegmental nucleus. Int. J. Neuropsychopharmacol. 21, 305\u2013310 (2018).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR76","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1017\/S1461145711001064","volume":"15","author":"X L\u00f3pez-Gil","year":"2012","unstructured":"L\u00f3pez-Gil, X. et al. Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists. Int. J. Neuropsychopharmacol. 15, 945\u2013956 (2012).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR77","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1021\/acschemneuro.9b00288","volume":"10","author":"X L\u00f3pez-Gil","year":"2019","unstructured":"L\u00f3pez-Gil, X. et al. Role of serotonin and noradrenaline in the rapid antidepressant action of ketamine. ACS Chem. Neurosci. 10, 3318\u20133326 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"1110_CR78","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ijnp\/pyz041","volume":"9","author":"Y Ago","year":"2019","unstructured":"Ago, Y. et al. (R)-ketamine induces a greater increase in prefrontal 5-HT release than (S)-ketamine and ketamine metabolites via an AMPA receptor-independent mechanism. Int. J. Neuropsychopharmacol. 9, 665\u2013674 (2019).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR79","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam, B., Adams, B. W., Verma, A. & Daly, D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17, 2921\u20132927 (1997).","journal-title":"J. Neurosci."},{"key":"1110_CR80","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","volume":"117","author":"DS Lorrain","year":"2003","unstructured":"Lorrain, D. S., Baccei, C. S., Bristow, L. J., Anderson, J. J. & Varney, M. A. Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117, 697\u2013706 (2003).","journal-title":"Neuroscience"},{"key":"1110_CR81","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbr.2016.06.041","volume":"312","author":"C Thelen","year":"2016","unstructured":"Thelen, C., Sens, J., Mauch, J., Pandit, R. & Pitychoutis, P. M. Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice. Behav. Brain Res. 312, 305\u2013312 (2016).","journal-title":"Behav. Brain Res."},{"key":"1110_CR82","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0165-0270(89)90150-7","volume":"29","author":"M Dragunow","year":"1989","unstructured":"Dragunow, M. & Faull, R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods 29, 261\u2013265 (1989).","journal-title":"J. Neurosci. Methods"},{"key":"1110_CR83","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1515\/REVNEURO.2004.15.6.383","volume":"15","author":"ATM Konkle","year":"2004","unstructured":"Konkle, A. T. M. & Bielajew, C. Tracing the neuroanatomical profiles of reward pathways with markers of neuronal activation. Rev. Neurosci. 15, 383\u2013414 (2004).","journal-title":"Rev. Neurosci."},{"key":"1110_CR84","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2826.2008.01734.x","volume":"20","author":"KJ Kov\u00e1cs","year":"2008","unstructured":"Kov\u00e1cs, K. J. Measurement of immediate-early gene activation-c-fos and beyond. J. Neuroendocrinol. 20, 665\u2013672 (2008).","journal-title":"J. Neuroendocrinol."},{"key":"1110_CR85","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/cercor\/bhr220","volume":"22","author":"L Llad\u00f3-Pelfort","year":"2012","unstructured":"Llad\u00f3-Pelfort, L., Santana, N., Ghisi, V., Artigas, F. & Celada, P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cereb. Cortex 22, 1487\u20131497 (2012).","journal-title":"Cereb. Cortex"},{"key":"1110_CR86","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1007\/s00213-015-3946-6","volume":"232","author":"A Casta\u00f1\u00e9","year":"2015","unstructured":"Casta\u00f1\u00e9, A., Santana, N. & Artigas, F. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Psychopharmacology 232, 4085\u20134097 (2015).","journal-title":"Psychopharmacology"},{"key":"1110_CR87","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1017\/S1461145709990319","volume":"12","author":"D Inta","year":"2009","unstructured":"Inta, D., Trusel, M., Riva, M. A., Sprengel, R. & Gass, P. Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications. Int. J. Neuropsychopharmacol. 12, 1133\u20131136 (2009).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1110_CR88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fncir.2013.00095","volume":"7","author":"BJ van Beugen","year":"2013","unstructured":"van Beugen, B. J., Gao, Z., Boele, H. J., Hoebeek, F. & De Zeeuw, C. I. High frequency burst firing of granule cells ensures transmission at the parallel fiber to purkinje cell synapse at the cost of temporal coding. Front. Neural Circuits 7, 95 (2013).","journal-title":"Front. Neural Circuits"},{"key":"1110_CR89","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1152\/jn.00626.2002","volume":"89","author":"RP Dum","year":"2003","unstructured":"Dum, R. P. & Strick, P. L. An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex. J. Neurophysiol. 89, 634\u2013639 (2003).","journal-title":"J. Neurophysiol."},{"key":"1110_CR90","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1093\/cercor\/bhn231","volume":"19","author":"E Kuramoto","year":"2009","unstructured":"Kuramoto, E. et al. Two types of thalamocortical projections from the motor thalamic nuclei of the rat: a single neuron-tracing study using viral vectors. Cereb. Cortex 19, 2065\u20132077 (2009).","journal-title":"Cereb. Cortex"},{"key":"1110_CR91","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0165-0173(96)00003-3","volume":"22","author":"G Percheron","year":"1996","unstructured":"Percheron, G., Franqois, C., Talbi, B., Yelnik, J. & Ffnelon, G. The primate motor thalamus. Brain Res. Rev. 22, 93\u2013181 (1996).","journal-title":"Brain Res. Rev."},{"key":"1110_CR92","doi-asserted-by":"publisher","first-page":"8106","DOI":"10.1073\/pnas.1414728112","volume":"112","author":"Fuchikami","year":"2015","unstructured":"Fuchikami et al. Optogenetic stimulation of infralimbic PFC reproduces ketamine\u2019s rapid and sustained antidepressant actions. PNAS 112, 8106\u20138111 (2015).","journal-title":"PNAS"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01110-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:04:07Z","timestamp":1670249047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1038\/s41398-020-01110-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.A. has received teaching honoraria from Lundbeck A\/S. He is also a member of the scientific advisory board of Neurolixis and a co-inventor of two patents on conjugated oligonucleotide sequences. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"427"}}